The startup develops a cannabidiol-based treatment that enhances the therapeutic effects of steroid therapy while minimizing associated side effects. This approach reduces the reliance on steroids, addressing safety concerns linked to their administration in patient care.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Steroid treatments, while effective for numerous inflammatory and autoimmune diseases, often lead to significant side effects, including osteoporosis, weight gain, increased risk of infection, and mood swings. Many patients require long-term steroid use, exacerbating these adverse effects, while others are refractory to steroid treatments altogether.
Solution
STERO Biotechs develops Cannabidiol (CBD)-based treatments designed to enhance the therapeutic effects of steroids while minimizing their associated side effects. Their approach leverages CBD's immunomodulatory and anti-inflammatory properties to either reduce the required steroid dosage or improve the efficacy of existing steroid treatments. STERO's lead product, ST-101, aims to provide a steroid-sparing solution for various autoimmune diseases, potentially improving patient outcomes and quality of life. Clinical trial data suggests that CBD administration can lead to a gradual decrease in steroid dosage over time and may even benefit patients who are initially unresponsive to steroid therapy.
Target Audience
The primary target audience includes individuals suffering from autoimmune and inflammatory diseases such as Crohn's disease, rheumatoid arthritis, lupus, and psoriasis who are currently undergoing or are candidates for steroid therapy.
Features
- Proprietary CBD-based formulations for various autoimmune and inflammatory diseases
- ST-101 targeted for steroid sparing in multiple indications
- Patent protection covering the use of CBD for enhancing steroid effects, reducing steroid dosage, and mitigating side effects
- Clinical trials ongoing for Crohn's disease, chronic urticaria (hives), and severe COVID-19
- Potential to improve outcomes for patients refractory to steroid treatments
- CBD sourced from any origin (synthetic or botanical) can be used in any combination, dosage, or delivery system